Телмисартан (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Телмисартан" in Russian language version.

refsWebsite
Global rank Russian rank
1st place
1st place
2nd place
3rd place
4th place
6th place
399th place
713th place
3rd place
10th place
3,912th place
low place
6th place
9th place
low place
low place
low place
low place
731st place
847th place

archive.org

  • Opie, Lionel H. Drugs for the heart / Lionel H. Opie, Bernard J. Gersh. — seventh. — Saunders, 2009. — ISBN 978-1-4160-6158-8.
  • "Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity". Hypertension. 43 (5): 993—1002. May 2004. doi:10.1161/01.HYP.0000123072.34629.57. PMID 15007034.

books.google.com

clincalc.com

doi.org

  • "Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity". Hypertension. 43 (5): 993—1002. May 2004. doi:10.1161/01.HYP.0000123072.34629.57. PMID 15007034.
  • "Telmisartan as metabolic modulator: a new perspective in sports doping?". Journal of Strength and Conditioning Research. 26 (3): 608—10. March 2012. doi:10.1519/JSC.0b013e31824301b6. PMID 22130396.
  • "Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway". Journal of Cellular and Molecular Medicine. 15 (7): 1572—81. July 2011. doi:10.1111/j.1582-4934.2010.01085.x. PMID 20477906.
  • "Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways". Hypertension. 55 (4): 869—79. April 2010. doi:10.1161/HYPERTENSIONAHA.109.143958. PMID 20176998.
  • "Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-δ activation". Diabetes. 62 (3): 762—74. March 2013. doi:10.2337/db12-0570. PMID 23238297.
  • "A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours". Vascular Health and Risk Management. 2 (3): 195—201. September 2006. doi:10.2147/vhrm.2006.2.3.195. PMID 17326326.{{cite journal}}: Википедия:Обслуживание CS1 (не помеченный открытым DOI) (ссылка)

drugs.com

medicaldialogues.in

nestarenie.ru

nih.gov

pubmed.ncbi.nlm.nih.gov

  • "Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity". Hypertension. 43 (5): 993—1002. May 2004. doi:10.1161/01.HYP.0000123072.34629.57. PMID 15007034.
  • "Telmisartan as metabolic modulator: a new perspective in sports doping?". Journal of Strength and Conditioning Research. 26 (3): 608—10. March 2012. doi:10.1519/JSC.0b013e31824301b6. PMID 22130396.
  • "Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway". Journal of Cellular and Molecular Medicine. 15 (7): 1572—81. July 2011. doi:10.1111/j.1582-4934.2010.01085.x. PMID 20477906.
  • "Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways". Hypertension. 55 (4): 869—79. April 2010. doi:10.1161/HYPERTENSIONAHA.109.143958. PMID 20176998.
  • "Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-δ activation". Diabetes. 62 (3): 762—74. March 2013. doi:10.2337/db12-0570. PMID 23238297.
  • "A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours". Vascular Health and Risk Management. 2 (3): 195—201. September 2006. doi:10.2147/vhrm.2006.2.3.195. PMID 17326326.{{cite journal}}: Википедия:Обслуживание CS1 (не помеченный открытым DOI) (ссылка)

sagepub.com

imr.sagepub.com

web.archive.org